- Ocular Therapeutix (NASDAQ:OCUL) prices its initial public offering of 5M shares of common stock at $13.00 per share. Underwriters over-allotment is 750K shares. Trading in the NASDAQ Global Market-listed issue starts today.
- The company uses its proprietary hydrogel technology to develop ophthalmic drug delivery systems and medical devices. It launched its ReSure Sealant for corneal incisions in February 2014.
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at MarketWatch.com (Oct 3, 2014)
at CNBC.com (Jul 25, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs